<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-160616</identifier>
<setSpec>0210-4806</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">The role of IGF-1 and the distribution of body fat in decreasing the number of prostate rebiopsies</dc:title>
<dc:description xml:lang="en">Objective. To assess the usefulness of IGF-1 and internal organ fat measured by bioelectrical impedance audiometry to avoid rebiopsies in patients with persistently high prostate-specific antigen (PSA) levels. Material and method. A prospective study was conducted with 92 patients who underwent prostate rebiopsy due to high PSA levels with negative results in the rectal examination and a lack of preneoplastic lesions. The patients previously had their IGF-1 levels measured and had undergone an impedance audiometry test using the abdominal Fat Analyser AB-140 TANITA system. We calculated the receiver operating characteristic (ROC) curves for the PSA levels, %PSA, internal organ fat and IGF-1 and PSA density. Results. Twenty-five patients were diagnosed with prostate cancer. These patients had significantly higher PSA, PSAd and IGF-1 values and a tendency towards higher internal organ fat levels and lower %PSA readings (p=.001, p=.003, p=.001, p=.24 and P=0.28, respectively). The ROC curve showed an area under the curve for IGF-1 and PSA of .82 and .81, respectively. Using the cutoff points for 95% sensitivity and using the 3 criteria as an indication of rebiopsy, 74% of the biopsies would have been spared, leaving undiagnosed only 1 patient with clinically significant cancer &#151;Gleason score&gt;7 (4+3)&#151;. The positive and negative predictive values for the set of variables were higher than for each one separately (PPV: 66/NPV: 63). The cost of both determinations was 82 euros. Conclusions. Our results suggest that measuring IGF-1 could significantly decrease the number of unnecessary rebiopsies in an inexpensive and safe manner (AU)</dc:description>
<dc:creator>Broseta, E</dc:creator>
<dc:creator>Budía, A</dc:creator>
<dc:creator>Martínez, M</dc:creator>
<dc:creator>Boronat, F</dc:creator>
<dc:creator>Morán, E</dc:creator>
<dc:creator>Cámara, R</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Objetivo. Valorar la utilidad del IGF-1 y la grasa en órganos internos medida por impedanciometría bioeléctrica para el ahorro de rebiopsias innecesarias en pacientes con persistencia de PSA elevado. Material y método. Estudio prospectivo en 92 pacientes sometidos a rebiopsia de próstata por PSA elevado con tacto rectal negativo y ausencia de lesiones preneoplásicas. Previamente se determinó el valor de IGF-1 y se realizó un test de impedanciometría mediante el sistema abdominal Fat Analyser AB-140 TANITA. Se calcularon las curvas ROC para el PSA, % PSA, grasa en órganos internos e IGF-1 y PSA densidad. Resultados. Veinticinco pacientes fueron diagnosticados de cáncer de próstata. Estos presentaron de forma significativa mayores valores de PSA, PSAd e IGF-1 y una tendencia a mayores valores de grasa en órganos internos y menores cifras de %PSA (p=0,001; p=0,003; p=0,001; p=0,24 y p=0,28 respectivamente). La curva ROC mostró un área bajo la curva del IGF-1 y del PSA de 0,82 y 0,81. Empleando los puntos de corte para la sensibilidad del 95% y usando los 3 criterios como indicación de rebiopsia se habría ahorrado un 74% de las biopsias dejando de diagnosticar únicamente a un paciente con cáncer clínicamente significativo &#151;&gt;Gleason 7(4+3)&#151;. Los valores predictivos positivo y negativo para el conjunto de las variables fue superior a las de cada una por separado (VPP: 66/VPN: 63). El coste de ambas determinaciones es de 82 euros. Conclusiones. Nuestros resultados sugieren que la medición de IGF-1 podría disminuir el número de rebiopsias innecesarias de forma significativa, barata e inocua (AU)</dc:description>
<dc:source>Actas Urol Esp;41(2): 82-87, mar. 2017. tab, graf</dc:source>
<dc:identifier>ibc-160616</dc:identifier>
<dc:title xml:lang="es">Papel del IGF-1 y la distribución de la grasa corporal para disminuir el número de rebiopsias prostáticas</dc:title>
<dc:subject>^d28614</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d11420^s22074</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d9951^s22012</dc:subject>
<dc:subject>^d51213^s22045</dc:subject>
<dc:subject>^d9951^s22016</dc:subject>
<dc:subject>^d51213^s22039</dc:subject>
<dc:subject>^d28607</dc:subject>
<dc:subject>^d28606</dc:subject>
<dc:subject>^d11914^s22009</dc:subject>
<dc:subject>^d30596^s22002</dc:subject>
<dc:subject>^d51213^s22074</dc:subject>
<dc:subject>^d22312^s22002</dc:subject>
<dc:subject>^d11914^s22016</dc:subject>
<dc:type>article</dc:type>
<dc:date>201703</dc:date>
</metadata>
</record>
</ibecs-document>
